Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Fojo

Showing results (51-60 of 180) with videos related to

Pageof 18
Sort By:
Histopathology|May 15, 2015
Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndromeYi-Shan Lee, Armando Filie, Diane Arthur, et al.
Cancer Research|July 26, 2000
Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cellsM V Blagosklonny, P C Bishop, R Robey, et al.
Biochemistry|April 16, 1996
Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cellsK M Barnes, B Dickstein, G B Cutler, et al.
Human Gene Therapy|January 1, 1991
Implantation of recombinant rat myocytes into adult skeletal muscle: a potential gene therapyA Salminen, H F Elson, L A Mickley, et al.
The Journal of Clinical Investigation|April 15, 1997
Gene rearrangement: a novel mechanism for MDR-1 gene activationL A Mickley, B A Spengler, T A Knutsen, et al.
Biochemical Pharmacology|December 24, 1996
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panelO Rixe, W Ortuzar, M Alvarez, et al.
Journal of the National Cancer Institute|April 20, 2000
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategyD Vandier, V Calvez, L Massade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance geneA T Fojo, D W Shen, L A Mickley, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 14, 1997
[Expression of ATP binding cassette superfamily (multidrug resistance-1, multidrug resistance-associated protein, human canalicular multispecific organ anion transporter) mRNA in etoposide and m-AMSA resistant cell lines]Y Matsumoto, M Matsumoto, M Minemura, et al.
Cancer Research|August 12, 1998
Bcl-xL is phosphorylated in malignant cells following microtubule disruptionM S Poruchynsky, E E Wang, C M Rudin, et al.
Pageof 18

Showing results (51-60 of 180) with videos related to

Sort By:
Pageof 18
Histopathology|May 15, 2015
Breast implant-associated anaplastic large cell lymphoma in a patient with Li-Fraumeni syndromeYi-Shan Lee, Armando Filie, Diane Arthur, et al.
Cancer Research|July 26, 2000
Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cellsM V Blagosklonny, P C Bishop, R Robey, et al.
Biochemistry|April 16, 1996
Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cellsK M Barnes, B Dickstein, G B Cutler, et al.
Human Gene Therapy|January 1, 1991
Implantation of recombinant rat myocytes into adult skeletal muscle: a potential gene therapyA Salminen, H F Elson, L A Mickley, et al.
The Journal of Clinical Investigation|April 15, 1997
Gene rearrangement: a novel mechanism for MDR-1 gene activationL A Mickley, B A Spengler, T A Knutsen, et al.
Biochemical Pharmacology|December 24, 1996
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panelO Rixe, W Ortuzar, M Alvarez, et al.
Journal of the National Cancer Institute|April 20, 2000
Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategyD Vandier, V Calvez, L Massade, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Intrinsic drug resistance in human kidney cancer is associated with expression of a human multidrug-resistance geneA T Fojo, D W Shen, L A Mickley, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 14, 1997
[Expression of ATP binding cassette superfamily (multidrug resistance-1, multidrug resistance-associated protein, human canalicular multispecific organ anion transporter) mRNA in etoposide and m-AMSA resistant cell lines]Y Matsumoto, M Matsumoto, M Minemura, et al.
Cancer Research|August 12, 1998
Bcl-xL is phosphorylated in malignant cells following microtubule disruptionM S Poruchynsky, E E Wang, C M Rudin, et al.
Pageof 18